Bruce R. Donald
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Bruce R. Donald has a total of 3 co-authors. Here are the top co-authors by number of shared publications:
Amy C. Anderson
Department of Pharmaceutical Sciences, University of Connecticut, Storrs, CT 06269
1 shared publicationCheng-Yu Chen
Department of Biochemistry, Duke University Medical Center, Durham, NC 27710, USA
1 shared publicationIvelin Georgiev
Department of Computer Science, Duke University, Durham, NC 27708-0129; and
1 shared publication
Latest Publications
- 10 March 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (10) , 3764-3769
Computational structure-based redesign of enzyme activity
We report a computational, structure-based redesign of the phenylalanine adenylation domain of the nonribosomal peptide synthetase enzyme gramicidin S synthetase A (GrsA-PheA) for a set of noncognate substrates for which the wild-type enzyme has little or virtually no specificity. Experimental validation of a set of top-ranked computationally predicted enzyme mutants shows significant improvement in the specificity for the target substrates. We further present enhancements to the methodology for computational enzyme redesign that are experimentally shown to result in significant additional improvements in the target substrate specificity. The mutant with the highest activity for a noncognate substrate exhibits 1/6 of the wild-type enzyme/wild-type substrate activity, further confirming the feasibility of our computational approach. Our results suggest that structure-based protein design can identify active mutants different from those selected by evolution.
- 10 March 2009
- Published by National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 106 (10) , 3764-3769
Computational structure-based redesign of enzyme activity
We report a computational, structure-based redesign of the phenylalanine adenylation domain of the nonribosomal peptide synthetase enzyme gramicidin S synthetase A (GrsA-PheA) for a set of noncognate substrates for which the wild-type enzyme has little or virtually no specificity. Experimental validation of a set of top-ranked computationally predicted enzyme mutants shows significant improvement in the specificity for the target substrates. We further present enhancements to the methodology for computational enzyme redesign that are experimentally shown to result in significant additional improvements in the target substrate specificity. The mutant with the highest activity for a noncognate substrate exhibits 1/6 of the wild-type enzyme/wild-type substrate activity, further confirming the feasibility of our computational approach. Our results suggest that structure-based protein design can identify active mutants different from those selected by evolution.